Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Carcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
557
|
91
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Adult Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2528
|
98
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Infection by Hepatozoon
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Recurrent urinary tract infection
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases
|
Disease or Syndrome
|
237
|
21
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
DOSAGE-SENSITIVE SEX REVERSAL
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
159
|
12
|
0.010 |
None |
< 0.001 |
1 |
|
2015 |
2015 |
Bacterial Vaginosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Infections
|
Disease or Syndrome
|
73
|
15
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Lymphoma, T-Cell, Cutaneous
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
367
|
5
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Urinary tract infection
|
group |
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases
|
Disease or Syndrome
|
219
|
14
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Toxoplasmosis
|
disease |
Infections
|
Disease or Syndrome
|
112
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Sezary Syndrome
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
196
|
7
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hepatitis C, Chronic
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
430
|
80
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Infective cystitis
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases
|
Disease or Syndrome
|
106
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Experimental Organism Basal Cell Carcinoma
|
phenotype |
Neoplasms
|
Neoplastic Process
|
437
|
63
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1143
|
75
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Monoclonal B-Cell Lymphocytosis
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
49
|
7
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Epithelioma
|
disease |
Neoplasms
|
Neoplastic Process
|
326
|
2
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stomach Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3720
|
652
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Colon Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2832
|
275
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Protozoan Infections
|
group |
Infections
|
Disease or Syndrome
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |